Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hot Flashes × Tamoxifen × Clear all

Phase

Status

Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 24 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Breast Cancer Female 2 Prostatic Neoplasms 1 Premenopausal Breast Cancer 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Hot Flashes 1 Carcinoma, Lobular 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1 Breast Cancer Subjects 1

Interventions

fezolinetant 1 bazedoxifene 1 Tamoxifen 1 Estrogens, Conjugated (USP) 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06440967 2026-04-06

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

Astellas Pharma Inc

Phase 3 Active not recruiting

Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡